• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性卵巢癌。来自吉尔达·拉德纳家族性卵巢癌登记处1981 - 1991年的658个家族报告。

Familial ovarian cancer. A report of 658 families from the Gilda Radner Familial Ovarian Cancer Registry 1981-1991.

作者信息

Piver M S, Baker T R, Jishi M F, Sandecki A M, Tsukada Y, Natarajan N, Mettlin C J, Blake C A

机构信息

Gilda Radner Familial Ovarian Cancer Registry, Roswell Park Cancer Institute, Buffalo, New York 14263.

出版信息

Cancer. 1993 Jan 15;71(2 Suppl):582-8. doi: 10.1002/cncr.2820710214.

DOI:10.1002/cncr.2820710214
PMID:8420680
Abstract

BACKGROUND

Because of the small number of cases (five) reported between 1929 and 1969 and a significant increase reported in the decade of the 1970s, the Familial Ovarian Cancer Registry was established in 1981 to study the occurrence of familial ovarian cancer in the United States.

METHODS

Any woman (with or without ovarian cancer herself) who contacted the Registry and demonstrated a familial history of ovarian cancer was added to the Registry as an index case.

RESULTS

From 1981 through May 31, 1991, 658 families for a total of 1568 cases of familial ovarian cancer were accessioned into the Registry. Of the 219 mothers and 251 daughters with familial ovarian cancer, the mean (58.5 years) and median (57.0 years) age at diagnosis of the mothers was significantly older than the mean (49.8 years) and median (49.0 years) ages of their daughters with ovarian cancer. Significantly more index cases without ovarian cancer had used oral contraceptives as compared to index cases with ovarian cancer (P < 0.001). Significantly more index cases with ovarian cancer used other estrogens as compared to index cases without ovarian cancer (P < 0.001). The Registry cases exhibited a higher proportion of serous adenocarcinoma, poorly differentiated adenocarcinoma, borderline carcinoma, and gonadoblastoma as compared to the 1978 SEER data. Mother and a minimum of one daughter was the most common relationship and was represented in 49.5% of the families with familial ovarian cancer. Sister-sister relationships were the second most frequent and accounted for 38.5% of the 658 families.

CONCLUSIONS

Familial ovarian cancer occurs most frequently in mother-daughter relationships followed by sister-sister and appears to be an autosomal dominant inheritance with variable penetrance.

摘要

背景

由于1929年至1969年期间报告的病例数较少(5例),且在20世纪70年代这十年间报告的病例数显著增加,因此于1981年设立了家族性卵巢癌登记处,以研究美国家族性卵巢癌的发病情况。

方法

任何联系登记处并证明有卵巢癌家族史的女性(无论其本人是否患有卵巢癌)均作为索引病例被纳入登记处。

结果

从1981年至1991年5月31日,共有658个家庭的1568例家族性卵巢癌病例被纳入登记处。在患有家族性卵巢癌的219名母亲和251名女儿中,母亲确诊时的平均年龄(58.5岁)和中位年龄(57.0岁)显著高于患卵巢癌女儿的平均年龄(49.8岁)和中位年龄(49.0岁)。与患有卵巢癌的索引病例相比,显著更多没有卵巢癌的索引病例使用过口服避孕药(P < 0.001)。与没有卵巢癌的索引病例相比,显著更多患有卵巢癌的索引病例使用过其他雌激素(P < 0.001)。与1978年监测、流行病学和最终结果(SEER)数据相比,登记处的病例中浆液性腺癌、低分化腺癌、交界性癌和性腺母细胞瘤的比例更高。母亲和至少一个女儿是最常见的关系,在患有家族性卵巢癌的家庭中占49.5%。姐妹关系是第二常见的,在658个家庭中占38.5%。

结论

家族性卵巢癌最常发生于母女关系,其次是姐妹关系,似乎是一种具有可变外显率的常染色体显性遗传。

相似文献

1
Familial ovarian cancer. A report of 658 families from the Gilda Radner Familial Ovarian Cancer Registry 1981-1991.家族性卵巢癌。来自吉尔达·拉德纳家族性卵巢癌登记处1981 - 1991年的658个家族报告。
Cancer. 1993 Jan 15;71(2 Suppl):582-8. doi: 10.1002/cncr.2820710214.
2
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
3
Characteristics of familial ovarian cancer: a report of the first 1,000 families in the Gilda Radner Familial Ovarian Cancer Registry.家族性卵巢癌的特征:吉尔达·拉德纳家族性卵巢癌登记处前1000个家庭的报告。
Eur J Gynaecol Oncol. 1996;17(3):169-76.
4
Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.有卵巢癌家族史的女性在预防性卵巢切除术后发生原发性腹膜癌。吉尔达·拉德纳家族性卵巢癌登记处报告。
Cancer. 1993 May 1;71(9):2751-5. doi: 10.1002/1097-0142(19930501)71:9<2751::aid-cncr2820710911>3.0.co;2-j.
5
Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry.吉尔达·拉德纳家族性卵巢癌登记处卵巢癌的组织病理学、国际妇产科联盟(FIGO)分期及BRCA基因突变状态。
Int J Gynecol Pathol. 2004 Jan;23(1):29-34. doi: 10.1097/01.pgp.0000101083.35393.cd.
6
Complex segregation analysis of pedigrees from the Gilda Radner Familial Ovarian Cancer Registry reveals evidence for mendelian dominant inheritance.对吉尔达·拉德纳家族性卵巢癌登记处的家系进行复杂分离分析,发现了孟德尔显性遗传的证据。
PLoS One. 2009 Jun 17;4(6):e5939. doi: 10.1371/journal.pone.0005939.
7
The Gilda Radner Familial Ovarian Cancer Registry 1981-2000.吉尔达·拉德纳家族性卵巢癌登记处,1981 - 2000年
Eur J Gynaecol Oncol. 2000;21(4):325-33.
8
Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: a study by the Gilda Radner Familial Ovarian Cancer Registry.登记病理学家与会诊病理学家对卵巢癌组织病理学的比较研究:吉尔达·拉德纳家族性卵巢癌登记处的一项研究
Gynecol Oncol. 2000 Aug;78(2):166-70. doi: 10.1006/gyno.2000.5840.
9
Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study.父系遗传早发性遗传性卵巢癌:家族性卵巢癌登记研究。
PLoS Genet. 2018 Feb 15;14(2):e1007194. doi: 10.1371/journal.pgen.1007194. eCollection 2018 Feb.
10
Risks of cancer among members of families in the Gilda Radner Familial Ovarian Cancer Registry.吉尔达·拉德纳家族性卵巢癌登记处家庭成员的癌症风险。
Cancer. 1995 Oct 15;76(8):1416-21. doi: 10.1002/1097-0142(19951015)76:8<1416::aid-cncr2820760818>3.0.co;2-d.

引用本文的文献

1
Precision prophylaxis: Identifying the optimal timing for risk-reducing salpingo-oophorectomy based on type of BRCA1 and BRCA2 cluster region mutations.精准预防:基于 BRCA1 和 BRCA2 簇区域突变类型,确定行预防性输卵管卵巢切除术的最佳时机。
Gynecol Oncol. 2020 Feb;156(2):363-376. doi: 10.1016/j.ygyno.2019.11.036. Epub 2020 Jan 7.
2
Family history in ovarian cancer referral population.卵巢癌转诊人群的家族史。
J Genet Couns. 1996 Mar;5(1):27-38. doi: 10.1007/BF01408663.
3
Hereditary breast cancer. Identifying and managing BRCA1 and BRCA2 carriers.
遗传性乳腺癌。BRCA1和BRCA2携带者的识别与管理。
Can Fam Physician. 1999 Jan;45:114-24.
4
Forth nightly review: hereditary ovarian carcinoma.第四次夜间查房:遗传性卵巢癌
BMJ. 1999 Mar 20;318(7186):786-9. doi: 10.1136/bmj.318.7186.786.
5
Segregation analysis of epithelial ovarian cancer in Finland.芬兰上皮性卵巢癌的分离分析。
Br J Cancer. 1998 May;77(9):1537-41. doi: 10.1038/bjc.1998.252.
6
Familial cluster of ovarian small cell carcinoma: a new mendelian entity?卵巢小细胞癌的家族聚集性:一种新的孟德尔式疾病实体?
J Med Genet. 1996 Apr;33(4):333-5. doi: 10.1136/jmg.33.4.333.
7
Cancer incidence in the first-degree relatives of ovarian cancer patients.卵巢癌患者一级亲属中的癌症发病率。
Br J Cancer. 1996 Jul;74(2):280-4. doi: 10.1038/bjc.1996.352.
8
Can you screen for ovarian cancer?你能筛查卵巢癌吗?
J Natl Med Assoc. 1995 Feb;87(2):109-12.
9
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.对145个乳腺癌-卵巢癌家族的遗传异质性评估。乳腺癌连锁协会。
Am J Hum Genet. 1995 Jan;56(1):254-64.